Third-generation tyrosine kinase inhibitor combined with pediatric-like intensive chemotherapy induced complete molecular remission in a rare case of de novo Philadelphia-positive T-ALL with p230 isoform
,
2 papers indexed here
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
,
To develop and validate a prognostic model based on palmitoylation‑related genes for risk stratification in acute myeloid leukemia (AML), and to explore its associations with the immune microenvironment, drug sensitivity, and single‑cell expression patterns. A five‑gene prognostic signature was constructed using univar...
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.